Teladoc Health, Inc.
Every calculator, already run for TDOC
Open the full toolkit →You have the numbers on TDOC. Get the argument.
A written report on which of these readings actually decide the outcome for Teladoc Health, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
24 analysts covering TDOCAnalyst Price Target Disagreement for Teladoc Health, Inc.
Wall Street's bull case implies +65% from the current price; the bear case implies -13%. A 79% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for TDOC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Teladoc Health, Inc.
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Te…
TDOC — frequently asked
Is TDOC a buy right now?
Wall Street's consensus rating on Teladoc Health, Inc. is Hold across 24 analysts, with a mean price target of $7.67 (+21% vs. the current $6.35). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is TDOC overvalued?
TDOC trades at — trailing earnings, against a DCF fair value of $19 per share. The current price implies -10% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is TDOC's next earnings date?
Teladoc Health, Inc. is next scheduled to report earnings around Oct 28, 2026. A full TDOC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Teladoc Health, Inc.?
Analysts covering Teladoc Health, Inc. (TDOC) range from a bear-case target of $5.50 to a bull-case high of $10.50, with a mean consensus target of $7.67 across 18 analysts. The spread of $5.00 (79% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Teladoc Health, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Teladoc Health, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full TDOC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Teladoc Health, Inc., in minutes. 3 free reports included with every account — no credit card required.